Consun Pharmaceutical Group Limited
HKEX:1681.HK
8.51 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 2,748.262 | 2,450.173 | 2,196.323 | 1,940.273 | 1,383.232 | 1,269.746 | 989.565 | 672.711 | 489.987 | 843.669 | 902.026 | 81.755 |
| Short Term Investments
| 834.942 | 589.172 | 230 | 0 | 0 | 0 | 0 | 0 | 0 | 250.9 | 0 | 0 |
| Cash and Short Term Investments
| 3,583.204 | 3,039.345 | 2,426.323 | 1,940.273 | 1,383.232 | 1,269.746 | 989.565 | 672.711 | 489.987 | 1,094.569 | 902.026 | 81.755 |
| Net Receivables
| 255.838 | 259.562 | 351.226 | 448.54 | 763.806 | 863.992 | 970.294 | 557.275 | 363.703 | 232.144 | 224.995 | 0 |
| Inventory
| 367.087 | 287.663 | 257.619 | 227.374 | 210.684 | 210.31 | 200.001 | 140.974 | 71.014 | 53.482 | 48.966 | 22.442 |
| Other Current Assets
| 71.951 | 47.684 | 35.245 | 42.51 | 51.926 | 52.107 | 24.791 | 19.045 | 35.484 | 16.334 | 16.702 | 340.861 |
| Total Current Assets
| 4,278.08 | 3,622.671 | 3,055.829 | 2,658.697 | 2,409.648 | 2,396.155 | 2,184.651 | 1,390.005 | 960.188 | 1,396.529 | 1,192.689 | 445.058 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 790.791 | 874.999 | 858.448 | 799.448 | 788.117 | 561.785 | 400.797 | 392.882 | 223.773 | 229.914 | 232.27 | 193.178 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 320.647 | 320.647 | 320.647 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 397.415 | 311.904 | 341.664 | 371.423 | 396.071 | 560.443 | 460.215 | 530.029 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 397.415 | 311.904 | 341.664 | 371.423 | 396.071 | 881.09 | 780.862 | 850.676 | 854.393 | 222.817 | 0 | 0 |
| Long Term Investments
| 9.23 | 6.5 | 1,153.253 | 1,111.986 | 1,138.246 | 1,407.773 | 2.6 | 2.6 | 639.259 | 2.6 | 2.6 | 0 |
| Tax Assets
| 17.844 | 36.432 | 46.859 | 58.885 | 45.942 | 35.102 | 34.714 | 18.334 | 8.639 | 9.697 | 0 | 5.171 |
| Other Non-Current Assets
| 14.634 | -36.432 | -1,200.112 | -1,170.871 | -1,184.188 | -1,442.875 | -34.714 | -18.334 | -863.032 | -232.514 | 29.386 | 2.6 |
| Total Non-Current Assets
| 1,229.914 | 1,193.403 | 1,200.112 | 1,170.871 | 1,184.188 | 1,442.875 | 1,184.259 | 1,246.158 | 863.032 | 232.514 | 264.256 | 200.949 |
| Total Assets
| 5,507.994 | 4,892.38 | 4,362.738 | 3,950.253 | 3,708.086 | 3,897.038 | 3,572.017 | 2,759.055 | 1,917.891 | 1,662.941 | 1,456.945 | 646.007 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 83.098 | 59.891 | 66.638 | 50.889 | 55.52 | 92.755 | 68.739 | 79.733 | 39.76 | 36.416 | 20.567 | 31.976 |
| Short Term Debt
| 507.636 | 454.229 | 602.426 | 549.414 | 553.567 | 147.202 | 193.621 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 43.38 | 32.889 | 2.536 | 71.108 | 69.461 | 99.492 | 95.336 | 62.133 | 27.679 | 27.133 | 0 | 9.548 |
| Deferred Revenue
| -4.218 | -454.229 | -602.426 | -549.414 | -553.567 | -147.202 | -193.621 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 860.882 | 803.479 | 685.807 | 660.452 | 617.746 | 659.704 | 612.537 | 404.865 | 161.911 | 114.698 | 129.548 | 218.823 |
| Total Current Liabilities
| 1,494.996 | 1,350.488 | 1,357.407 | 1,331.863 | 1,296.294 | 999.153 | 970.233 | 546.731 | 229.35 | 178.247 | 150.115 | 260.347 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 3.898 | 5.947 | 8.547 | 0 | 0 | 245.336 | 374.483 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 19.179 | 18.929 | 16.7 | 15.629 | 16.739 | 18.32 | 20.741 | 21.603 | 11.582 | 12.018 | 0 | 1.898 |
| Deferred Tax Liabilities Non-Current
| 71.209 | 78.011 | 69.303 | 86.263 | 88.292 | 137.217 | 142.412 | 129.67 | 40.204 | 39.49 | 0 | 28.584 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.899 | 0 |
| Total Non-Current Liabilities
| 94.286 | 102.887 | 94.55 | 101.892 | 105.031 | 245.336 | 374.483 | 151.273 | 51.786 | 51.508 | 0 | 30.482 |
| Total Liabilities
| 1,589.282 | 1,453.375 | 1,451.957 | 1,433.755 | 1,401.325 | 1,400.026 | 1,507.869 | 698.004 | 281.136 | 229.755 | 150.115 | 290.829 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 63.812 | 63.45 | 64.8 | 64.424 | 68.033 | 68.782 | 68.652 | 76.237 | 78.074 | 78.25 | 78.25 | 0.001 |
| Retained Earnings
| 3,140.726 | 2,913.166 | 2,392.552 | 2,003.204 | 1,640.449 | 1,782.248 | 1,316.895 | 1,133.553 | 836.814 | 587.125 | 375.925 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 3,562.691 | 251.696 | 253.888 | 241.381 | 228.842 | 206.925 | 202.511 | 185.216 | 163.927 | 83.21 | 80.588 | -59.149 |
| Other Total Stockholders Equity
| -65.028 | -83.173 | -93.535 | -88.642 | 56.76 | 99.264 | 158.63 | 365.488 | 557.94 | 684.601 | 722.601 | 414.326 |
| Total Shareholders Equity
| 3,626.503 | 3,145.139 | 2,617.705 | 2,220.367 | 1,994.084 | 2,157.219 | 1,746.688 | 1,760.494 | 1,636.755 | 1,433.186 | 1,257.364 | 355.178 |
| Total Equity
| 3,918.712 | 3,439.005 | 2,910.781 | 2,516.498 | 2,306.761 | 2,497.012 | 2,064.148 | 2,061.051 | 1,636.755 | 1,433.186 | 1,257.364 | 355.178 |
| Total Liabilities & Shareholders Equity
| 5,507.994 | 4,892.38 | 4,362.738 | 3,950.253 | 3,708.086 | 3,897.038 | 3,572.017 | 2,759.055 | 1,917.891 | 1,662.941 | 1,456.945 | 646.007 |